Not sure if there are any holders on here but here go's.



Johnson Matthey is a speciality chemicals company focused on its core skills in catalysis, precious metals, fine chemicals and process technology. Johnson Matthey's principal activities are the manufacture of autocatalysts, heavy duty diesel catalysts and pollution control systems, catalysts and components for fuel cells, catalysts and technologies for chemical processes, fine chemicals, chemical catalysts and active pharmaceutical ingredients and the marketing, refining, and fabrication of precious metals. Johnson Matthey has continued to develop its technology for almost 200 years, demonstrating the company's ability to maintain world leadership by adapting constantly to rapidly changing customer needs. Rigorous in its own environmental policies, many of Johnson Matthey's products have a major beneficial impact on the environment and enhance the quality of life for millions of people around the world. Johnson Matthey has operations in over 30 countries and employs around 9,000 people. Its products are sold across the world to a wide range of advanced technology industries. The group is organised into three global divisions: Environmental Technologies; Precious Metal Products and Fine Chemicals.

why so strong when even gold is slumping still?

someone must have heard what i said

Not quite sure what the correlation is between gold and JMAT.

i always thought of JMAT as precious metals traders
perhaps they've changed their coat over the years

I seem to remember that JMAT said or it was said about them that they would be having less exposure to catalytic converters, also the special divi has and may well have an impact on the SP movement up until Jan. I have amended some details in the opening post for info about their activities.

Q3 Trading update http://www.moneyam.com/action/news/showArticle?id=5206138

Ameriprise Financial, Inc. and its group go above 5% http://www.moneyam.com/action/news/showArticle?id=5214104

StockMarketWire.com
Johnson Matthey reports a robust performance for the year to the end of March in challenging markets with continued investment for future growth.

Overall, sales were flat at £3.2 billion, underlying operating profit was 6% down at £450.8 million and underlying profit before tax was 5% lower at £418.2 million.

Underlying return on sales was slightly lower than last year at 14.2%. On a continuing basis, adjusting for the disposals of Gold and Silver Refining and Research Chemicals, sales grew by 3% and underlying profit before tax was flat.

Profit before tax was £386.3 million which includes both the benefit of the £130 million profit on the sale of Research Chemicals and the negative impact of a £141 million impairment and restructuring charge. Basic earnings per share were 166.2 pence.

Chief executive Robert MacLeod said: "Johnson Matthey has delivered a robust performance overall in a year where conditions have been particularly tough in some of our markets. Emission Control Technologies had another strong year and we have made good progress in New Businesses. The group's performance was adversely impacted by the challenging conditions in some of our other business areas and we have restructured our business; results in 2016/17 will benefit from those actions.

"We continued to focus on health and safety and our lost time injury and illness rate reduced. However, this was overshadowed by a tragic accident in July 2015 when an employee at our Fine Chemicals' facility in Riverside, USA suffered fatal injuries. This incident has further reinforced our efforts to achieve a world class health and safety culture across Johnson Matthey.

"Looking ahead to 2016/17, we expect performance to be ahead of 2015/16 and in line with current market expectations. Johnson Matthey remains well positioned in markets with strong growth drivers. Our strong cash generation and balance sheet provide the resources for investment, and we continue to increase R&D and capital expenditure to drive future growth. Supported by a clear purpose and strategy, Johnson Matthey will continue to deliver long term growth for our shareholders through the creation of value adding sustainable technologies."

StockMarketWire.com
Johnson Matthey (JMAT) said group sales for the continuing businesses increased by 6% to £822 million (up 2% at constant rates).

This was supported by continued good demand in Emission Control Technologies and an increasing contribution from new businesses.

Sales in both Process Technologies and Precious Metal Products were stable although markets in both divisions remained challenging. Demand in Fine Chemicals' continuing businesses was steady.

Underlying profit before tax for the quarter was supported by actions taken to reduce costs in the last financial year.

The company's outlook for the full year at constant rates is unchanged.

If current exchange rates prevail for the remainder of 2016/17, the group's reported results will further benefit from a positive translational impact.

StockMarketWire.com
Johnson Matthey's first half sales were up 5% and underlying pre-tax profits rose by 5%.

The group said its performance at constant rates was on-track and in line with its previous expectations.

The full year outlook for continuing businesses at constant rates is unchanged and the group expects performance to be slightly ahead of last year.

First half revenues totalled £5,625m - down 2% at actual rates and 6% down at constant rates. Sales excluding precious metals totalled £1,676m - up 5% at actual rates and down 1% at constant rates. Underlying PBT was £219.6m - up 5% at actual rates and donw 3% at constant rates.

Chief executive Robert MacLeod said: "Johnson Matthey had a solid first half, supported by favourable exchange rates, and our health and safety performance improved. Trading for the group during the period was in line with our expectations in our continuing businesses on a constant currency basis. We have increased our interim dividend by 5% reflecting our confidence in the medium term.

"I am pleased with the performance of Emission Control Technologies (ECT), where strong growth in Europe and Asia offset the expected cyclical weakness in North America. New Businesses made good progress and Process Technologies has maintained its strong position in tough markets. In Fine Chemicals, first half performance was held back by an unfavourable product mix in our Active Pharmaceutical Ingredient (API) Manufacturing business.

"Our guidance for the full year remains unchanged for our continuing businesses on a constant currency basis; that we expect the group's performance to be slightly ahead of last year. In addition, the group will benefit from favourable exchange rates if current rates are maintained.

"Johnson Matthey remains well positioned in growth markets. Through continued investment in R&D, our infrastructure and our people, we will continue to deliver both long term growth for shareholders and sustainable technologies that make the world around us cleaner and healthier."

"As the weakening of sterling versus other major currencies in the first half had a material impact on the reported performance of the business, we have focused commentary on performance at constant rates. Unless otherwise stated, commentary refers to performance at constant rates."

Final Results http://www.moneyam.com/action/news/showArticle?id=5559448

Some salient points:

Johnson Matthey posted solid growth in sales and profits for the year to 31 March, with revenue up 12% and profit before tax up 19%, helped by a big currency benefit. The chemicals group recommended a final dividend per share of 54.5p, that lifted the full year payout to 75p, a 5% annual increase that the company said reflected confidence in its medium term prospects.

Up 12% on news today.

Half yearly report http://www.moneyam.com/action/news/showArticle?id=5751065

Collaboration sends JMAT shares higher http://http://www.moneyam.com/action/news/showArticle?id=5837823

JMAT awarded contract http://www.moneyam.com/action/news/showArticle?id=6118462

Half year report https://www.moneyam.com/action/news/showArticle?id=621527

The Chairman splashes out https://www.moneyam.com/action/news/showArticle?id=6283944